- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations Investing
- Private Equity
- Real Estate
- Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy
- Financial Services
- Food and Beverage
- Franchise and Hospitality
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- Buy American
- COVID-19 Vaccine Rollout
- Coronavirus
- Crisis Practice
- Environmental Agenda
- Focus on Women's Health
- Special Purpose Acquisition Companies (SPACs)
- The New Administration: Enforcement and Legislative Impact
- Careers
- News & Insights
- About
- Languages
Event 179 results
Speaking Engagement
October 12, 2021
Heather Bañuelos to Speak at Food and Drug Law Institute’s Introduction to Advertising and Promotion for Medical Products Conference
Webinar
September 22, 2021
Key Food and Beverage Issues – Social and Environmental Responsibility in Manufacture, Supply and Advertising
Speaking Engagement
September 21, 2021
Grant Nichols, Amy Boring, Shannon Cox to Speak at Society of Corporate Compliance and Ethics’ 20th Annual Compliance & Ethics Institute
Speaking Engagement
September 14, 2021
Heather Bañuelos to Speak at RAPS Convergence 2021
Webinar
September 9, 2021
14th Annual King & Spalding Medical Device Summit
Speaking Engagement
July 29, 2021
Heather Banuelos to Speak at Q1 Productions 10th Annual Life Science Medical & Scientific Communications Conference
Webinar
July 28, 2021
COVID-Related Litigation and the PREP Act: A Year Later
Webinar
June 15, 2021
Real-World Evidence: The Evolving Landscape for FDA and EU Decision-Making About Drugs, Biologics, and Medical Devices
Speaking Engagement
June 15, 2021
Chris Markus to Speak About Gene & Cell Therapy Manufacturing at Global Regulatory Affairs Conference
Speaking Engagement
May 26, 2021
Heather Bañuelos, Gillian Russell to Co-Present OPDP & FTC Enforcement Trends Webinar
Speaking Engagement
May 25, 2021
Chris Markus to Speak at 10th Annual Global Pharma Regulatory Summit